Abstract
Recent studies have increasingly highlighted a potential link between gut microbiota (GM) and chronic pain. However, existing research has yielded mixed results, leaving many questions unanswered. We employed a two-sample Mendelian randomization design to investigate whether GM directly influences multisite chronic pain (MCP) and eight phenotypes. We then used a combination of meta-analysis, genetic colocalization analysis, and Bayesian weighted mendelian randomization to further strengthen the evidence for causal relationship. Additionally, we examined how GM might be associated with human brain structures. Finally, we used mediation analysis to explore whether the structure and function of specific brain regions play a role in the relationship between GM and MCP and the pain phenotypes.
We observed a significant causal association between 13 GM and chronic pain. Eight GM protected against pain phenotypes, whereas seven increased risk. The results indicate that GM could potentially affect the area, thickness, and volume of brain region cortices involved in sensory, emotional, and cognitive aspects of pain. Importantly, our findings indicated that the causal effect between the Genus Odoribacter and neck/shoulder pain could be mediated by the mean optical density in the left Fornix cres+Stria terminalis. In conclusion, different pain phenotypes were causally associated with different GM among European ancestry. Core GM may influence chronic pain by affecting complex brain networks. Notably, we constructed a basic gut-brain axis model for neck/shoulder pain, involving the Genus Odoribacter, left Fornix cres+Stria terminalis, and neck/shoulder pain.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was received for this research.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Our analyses were based on publicly available data that had been approved by relevant review boards. Therefore, no additional ethical approval is required.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵# Co-first author
Funding: No funding was received for this research. Declaration of competing interest None declared.
Competing interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Data availability: All relevant data are within the manuscript and its Supplementary Material.
Data Availability
All relevant data are within the manuscript and its Supplementary Material.
